An IP monolith in Colombia and the wider region, OlarteMoure ‘always seeks effective solutions for problems’, with clients especially lauding its expertise in in pharmaceutical-related work ’where it is among the best in LatAm’. Possessing one of the most sizeable teams in the market, spread between five offices across Colombia and a platform in Japan, the deep bench draws on 11 specialist partners and fields standalone offerings in patents, trade marks, copyright and entertainment, litigation, and anticounterfeiting, among other areas. Key contacts include co-founding partner Carlos Olarte, who is a go-to specialist for patent matters; Juan Moure, who heads the trade mark section; Alexander Agudelo, who leads the patent department and recently paired up with Olarte to represent Ericsson in landmark standard essential patent (SEP) infringement litigation against Apple; and Juan Felipe Acosta, who fronts the litigation and ADR unit. The team also saw a clutch of senior-level promotions in October 2023: trade mark director María Alejandra Pava, patent director Mónica Guevara and Cali office head Isabella Herrera were all elevated to the partnership. A deep pool of non-partners includes director Liliana Galindo Díaz, who heads the patent litigation practice, and Valeria Jaramillo, who serves as the director of the innovation, protection and technology-transfer team.
Testimonials
Collated independently by Legal 500 research team.
‘Whenever we have a question or require a specific procedure in Colombia, OlarteMoure is definitely one of the best options to satisfy our needs. It always seeks effective solutions for problems and concerns that arise; especially in pharma patents and pharma patent litigation where it is among the best in LatAm.’
‘The members of OlarteMoure remain aligned with the business vision of their firm: they remain up-to-date and work with the objective of providing clients with optimal and quality service. We have worked with Carlos Olarte, who is a specialised patent lawyer.’
Key clients
- Ericsson
- Immatics Biotechnologies
Work highlights
- Represented Ericsson in landmark standard essential patent (SEP) infringement litigation against Apple.
- Prosecuted portfolios of patent applications in Latin America for Immatics Biotechnologies, Novartis, Merck, Pfizer, GlaxoSmithKline, Bristol-Myers Squibb and Bayer Intellectual Property.